Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion type Assertion NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_head.
- NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion description "[Although anti-VEGF therapy is widely used in high-grade gliomas, no predictor of response or toxicity has been reported yet.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_provenance.
- NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion evidence source_evidence_literature NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_provenance.
- NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion SIO_000772 25488073 NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_provenance.
- NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion wasDerivedFrom befree-2016 NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_provenance.
- NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_assertion wasGeneratedBy ECO_0000203 NP1246270.RAe1HC3UJ0I6MeHusmkodAJCdAx-ea5FbD3uKDmTF8iyo130_provenance.